Dr. Michael Kelberman, MD

Interventional Cardiology Utica, NY Male
NPI: 1659379212
Total Payments
$6,526
2024 Payments
$778.56
Companies
27
Transactions
172
Medicare Patients
10,578
Medicare Billing
$1.3M

Payment Breakdown by Category

Food & Beverage$4,656 (71.3%)
Travel$1,521 (23.3%)
Other$300.00 (4.6%)
Education$49.48 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,656 165 71.3%
Travel and Lodging $1,521 3 23.3%
Honoraria $300.00 1 4.6%
Education $49.48 3 0.8%

Top Paying Companies

Company Total Records Latest Year
Boston Scientific Corporation $2,906 22 $0 (2024)
Novartis Pharmaceuticals Corporation $507.70 45 $0 (2024)
Edwards Lifesciences Corporation $399.75 3 $0 (2018)
ABIOMED $337.56 3 $0 (2021)
Boehringer Ingelheim Pharmaceuticals, Inc. $333.17 16 $0 (2024)
W. L. Gore & Associates, Inc. $300.00 1 $0 (2017)
Merck Sharp & Dohme LLC $212.10 14 $0 (2024)
AtriCure, Inc. $188.40 3 $0 (2018)
Lexicon Pharmaceuticals, Inc. $169.27 4 $0 (2024)
Janssen Pharmaceuticals, Inc $146.89 11 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $778.56 45 Novartis Pharmaceuticals Corporation ($179.52)
2023 $454.72 21 Novartis Pharmaceuticals Corporation ($106.61)
2022 $598.61 30 Boston Scientific Corporation ($149.11)
2021 $388.06 12 Alnylam Pharmaceuticals Inc. ($125.00)
2020 $281.19 6 ABIOMED ($227.81)
2019 $742.79 19 Boston Scientific Corporation ($608.12)
2018 $2,504 23 BOSTON SCIENTIFIC CORPORATION ($1,996)
2017 $778.47 16 W. L. Gore & Associates, Inc. ($300.00)

All Payment Transactions

172 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/11/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $26.30 General
Category: DIABETES
12/04/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $14.14 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/19/2024 E.R. Squibb & Sons, L.L.C. — Food and Beverage Cash or cash equivalent $36.15 General
11/14/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $4.49 General
Category: Cardiology/Vascular Diseases
10/29/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $13.12 General
Category: Cardiology
10/29/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $4.89 General
Category: Cardiology/Vascular Diseases
10/04/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $11.02 General
Category: Cardiology/Vascular Diseases
09/26/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $5.11 General
Category: Cardiology/Vascular Diseases
09/26/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $0.89 General
Category: Cardiology/Vascular Diseases
09/15/2024 Medtronic, Inc. MICRA (Device) Food and Beverage In-kind items and services $30.55 General
Category: Pacemakers
09/11/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $19.49 General
Category: Cardiology/Vascular Diseases
09/09/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $28.96 General
Category: DIABETES
08/29/2024 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $123.04 General
Category: Inhibitor of SGLT2 and SGLT1
08/27/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.27 General
Category: DIABETES
08/26/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $10.06 General
Category: Cardiology/Vascular Diseases
08/05/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $5.59 General
Category: Cardiology/Vascular Diseases
08/05/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $0.89 General
Category: Cardiology/Vascular Diseases
07/31/2024 Lexicon Pharmaceuticals, Inc. — Food and Beverage In-kind items and services $15.12 General
07/30/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $14.90 General
Category: Cardiology/Vascular Diseases
07/11/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $4.19 General
Category: Cardiology/Vascular Diseases
07/11/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $0.87 General
Category: Cardiology/Vascular Diseases
06/25/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $12.65 General
Category: Cardiology/Vascular Diseases
06/25/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $0.09 General
Category: Cardiology/Vascular Diseases
06/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.00 General
Category: DIABETES
06/21/2024 Kiniksa Pharmaceuticals International, plc Arcalyst (Drug) Food and Beverage In-kind items and services $20.40 General
Category: Not Applicable
123…7»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 22 2,459 3,514 $834,943 $334,842
2022 24 2,494 3,458 $813,527 $329,453
2021 23 3,013 4,378 $867,879 $361,264
2020 23 2,612 3,702 $731,132 $301,391
Total Patients
10,578
Total Services
15,052
Medicare Billing
$1.3M
Procedure Codes
100

All Medicare Procedures & Services

100 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2023 189 189 $154,426 $63,178 40.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 414 522 $91,350 $48,873 53.5%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 323 323 $157,321 $42,381 26.9%
78431 Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan Office 2023 32 32 $112,000 $41,057 36.7%
J2785 Injection, regadenoson, 0.1 mg Office 2023 216 868 $56,186 $37,588 66.9%
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries Office 2023 32 64 $27,200 $21,824 80.2%
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose Office 2023 188 376 $21,432 $17,012 79.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 172 181 $19,910 $10,942 55.0%
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician Office 2023 220 221 $82,875 $10,727 12.9%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2023 164 166 $23,600 $8,407 35.6%
93351 Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report Office 2023 39 39 $20,475 $6,569 32.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 47 48 $15,360 $6,522 42.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 42 42 $11,550 $4,947 42.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 25 28 $8,400 $3,549 42.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 30 47 $5,170 $2,865 55.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 20 32 $4,960 $2,838 57.2%
93320 Ultrasound of heart blood flow, valves and chambers Office 2023 35 35 $6,125 $1,381 22.5%
93280 Programming of dual lead pacemaker system Office 2023 21 21 $2,625 $1,178 44.9%
93290 Evaluation of implantable heart and blood vessel monitoring system Office 2023 19 22 $1,320 $883.26 66.9%
93325 Ultrasound of heart with color-depicted blood flow, rate and valve function Office 2023 35 35 $4,550 $637.35 14.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 55 55 $4,125 $569.61 13.8%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 69 84 $1,464 $504.02 34.4%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2023 53 53 $1,714 $280.72 16.4%
85610 Blood test, clotting time Office 2023 19 31 $806.00 $130.20 16.2%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2022 182 183 $150,226 $63,503 42.3%
1234»

About Dr. Michael Kelberman, MD

Dr. Michael Kelberman, MD is a Interventional Cardiology healthcare provider based in Utica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659379212.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kelberman, MD has received a total of $6,526 in payments from pharmaceutical and medical device companies, with $778.56 received in 2024. These payments were reported across 172 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,656).

As a Medicare-enrolled provider, Kelberman has provided services to 10,578 Medicare beneficiaries, totaling 15,052 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.

Practice Information

  • Specialty Interventional Cardiology
  • Location Utica, NY
  • Active Since 07/08/2005
  • Last Updated 07/13/2012
  • Taxonomy Code 207RI0011X
  • Entity Type Individual
  • NPI Number 1659379212

Products in Payments

  • WATCHMAN (Device) $2,191
  • Impella (Device) $337.56
  • Product in Development (Device) $300.00
  • ENTRESTO (Drug) $293.50
  • GENERAL STENTS (Device) $291.28
  • WATCHMAN Access System (Device) $285.73
  • Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $265.52
  • JARDIANCE (Drug) $224.69
  • LEQVIO (Drug) $214.20
  • VERQUVO (Drug) $212.10
  • XARELTO (Drug) $146.89
  • Inpefa (Drug) $138.81
  • ONPATTRO (Drug) $125.00
  • ELIQUIS (Drug) $123.27
  • MICRA (Device) $122.55
  • EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS (Device) $110.50
  • PRADAXA (Drug) $108.48
  • Epi-Sense Guided Coagulation System with VisiTrax, Models (Device) $77.90
  • Arcalyst (Drug) $76.90
  • Repatha (Biological) $74.95

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Interventional Cardiology Doctors in Utica

Dr. Michael Sassower, Md, MD

Interventional Cardiology — Payments: $29,660

Interventional Cardiology $29,660

Hugh Macisaac, Md, MD

Interventional Cardiology — Payments: $10,951

Interventional Cardiology $10,951

Prabhat Varma, Md, MD

Interventional Cardiology — Payments: $7,372

Interventional Cardiology $7,372

Ashok Patel, Md, MD

Interventional Cardiology — Payments: $5,867

Interventional Cardiology $5,867

Rakesh Bhan, Md, MD

Interventional Cardiology — Payments: $3,879

Interventional Cardiology $3,879

Ramzi Nassif, Md, MD

Interventional Cardiology — Payments: $3,228

Interventional Cardiology $3,228